Chemotherapy-induced nausea and vomiting (CINV) represents one of the most distressing and debilitating side effects ...

Study shows social isolation following immune challenge is self-imposed and driven by an active neural process, rather than a secondary consequence of physiological symptoms of sickness.

Blocking a receptor involved in prostaglandins reduces pain while allowing inflammation to proceed normally, according to findings from animal and cell studies. Researchers at the NYU Pain Research ...

New analysis examines RAP-219’s effect during the first month of treatment and consistency of efficacy over the treatment ...

Ischemic stroke is a complex cerebrovascular disorder characterized by highly unpredictable outcomes influenced by ...

Effective axon regeneration is critical for restoring nerve function in patients with axon injury-related neurological ...

A rare case describes onset of myasthenia gravis, neuromyelitis optica, and anti-N-methyl-D-aspartate receptor in one woman, ...

Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes ...

Novartis today announced that the US Food and Drug Administration (FDA) has approved Itvisma® (onasemnogene?abeparvovec-brve) for the treatment of children two years and older, teens, and adults ...

Consumers want solutions offering multifaceted benefits for sleep, stress, and cognitive function, putting retailers in ...

ELZONRIS was approved by the FDA in December 2018 for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adult and pediatric patients two years and older, in both treatment-naïve ...

Researchers from The University of Texas at Dallas' Center for Advanced Pain Studies (CAPS) and their colleagues have made a ...